Ardelyx ARDX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Product | ||||||
| IBSRELA | $299.88M+9.4% | $274.21M+13.6% | $241.45M+18.4% | $203.93M+17.0% | $174.33M+10.1% | |
| Licensing revenue | $119K-97.7% | $5.09M0.0% | $5.09M+0.1% | $5.08M0.0% | $5.08M+6,414% | |
| Non-cash royalty revenue related to the sale of future royalties | $503.43M-0.1% | $503.76M+0.1% | $503.32M+12,084% | $4.13M+23.3% | $3.35M+24.4% | |
| Product supply revenue | $15.98M+0.6% | $15.88M+49.4% | $10.63M-33.4% | $15.95M+63.1% | $9.78M-16.1% | |
| XPHOZAH | $103.49M-0.1% | $103.6M-22.1% | $132.96M-15.3% | $157.06M-7.2% | $169.17M+5.1% | |
| Cost of Sales by Product | ||||||
| Other cost of revenue | $20.33M-28.3% | $28.35M-21.2% | $35.99M-26.1% | $48.68M+2.4% | $47.55M+8.8% | |
| Product sales, net | $11.72M+4.8% | $11.19M+2.0% | $10.97M+9.5% | $10.02M+22.5% | $8.18M+19.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Ardelyx break its business down?
- Ardelyx (ARDX) reports total revenues by product across 5 parts — IBSRELA, Licensing revenue, Non-cash royalty revenue related to the sale of future royalties, Product supply revenue and XPHOZAH. Each is extracted from the segment footnotes and tracked over time.
- Where does Ardelyx's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ardelyx's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
